Sorafenat (Sorafenib)

Description

Sorafenib Tosylate tablets are primarily used in the treatment of advanced or metastatic renal cell carcinoma (RCC) and hepatocellular carcinoma (HCC). It is a multikinase inhibitor that works by inhibiting multiple signaling pathways involved in tumor growth and angiogenesis.

Sorafenat is an anticancer medicine whose main content is:

Composition (active ingredient)

• Sorafenib – 200 mg per tablet

Drug class

• Tyrosine kinase inhibitor (TKI)
• Anti-cancer / anti-neoplastic medicine

How it works (content action)

Sorafenib works by blocking specific enzymes (kinases) that help cancer cells grow and form new blood vessels. By inhibiting these signals, it:

• Slows down cancer cell growth
• Reduces tumor blood supply
• Helps control spread of cancer

Uses (indications)

It is commonly used in:

• Liver cancer (hepatocellular carcinoma)
• Kidney cancer (renal cell carcinoma)
• Thyroid cancer (advanced, radioactive iodine–resistant)

Common side effects

• Fatigue
• Diarrhea
• Nausea or vomiting
• Loss of appetite
• Weight loss
• Hair loss
• Skin rash / hand-foot skin reaction
• High blood pressure

Important safety points

• Prescription-only cancer medicine
• Usually taken on an empty stomach
• Requires regular monitoring (blood pressure, liver tests, etc.)
• Not recommended in pregnancy